Skip to main content

Peer Review reports

From: Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0–1 non-small cell lung cancer: the INCREASE trial

Original Submission
23 Mar 2020 Submitted Original manuscript
2 Jun 2020 Reviewed Reviewer Report
20 Jul 2020 Reviewed Reviewer Report
1 Aug 2020 Author responded Author comments - Chris Dickhoff
Resubmission - Version 2
1 Aug 2020 Submitted Manuscript version 2
5 Aug 2020 Editorially accepted
14 Aug 2020 Article published 10.1186/s12885-020-07263-9

You can find further information about peer review here.

Back to article page